Johns Lyng grows its profit by 84% and upgrades guidance due to increased restorative work, leaving shareholders very pleased
Johns Lyng Group (ASX:JLG) delivered the best 1HY23 result of the companies reporting this morning. The company has been one of the few beneficiaries of catastrophic weather events that have occurred in recent months.
No time to do stock research, but you still want to invest?
Stocks Down Under Concierge gives you timely BUY and SELL alerts on ASX-listed stocks!
With price targets, buy ranges, stop loss levels and Sell alerts too.
GET A 3-MONTH FREE TRIAL TO CONCIERGE TODAY
Johns Lyng Group grows its profit by 84%
Johns Lyng Group recorded $635.6m in revenue, up 71% from 1HY22.
Revenue from the company’s Insurance Building and Restoration Services (IBRS) division increased by 62% to $374.8m, but revenue from Catastrophe work rose 179% to $186.1m. The latter was due to increased catastrophic weather events, particularly Hurricane Ian in the US.
The company’s Net Profit After Tax came in at $34.1m, up 84%, and its EPS was 9.68c, up 88%. There was also strong EBITDA growth, with the $59.4m result being 63% higher than 12 months.
Nonetheless, Johns Lyng Group only paid a dividend of 4.5c per share, which was only 47% of NPAT and a yield of only 1.4% on an annualised basis.
The company’s shares are up 12% today and up over 360% in the last five years.
Johns Lyng Group (ASX:JLG) share price chart, log scale (Source: TradingView)
Upgraded guidance
This result caused the company to update its guidance for FY23.
It is now expecting $1.15bn in revenue, up 15% from FY22 and an 11.2% upgrade from the original guidance, along with $111.1m in EBITDA, which would represent a 13% increase from FY22 and is a 5.5% upgrade from previous guidance.
Investors might argue that this result was a one-off but the company disagrees. CEO Scott Didier claimed that the value and duration of catastrophic events has been increasing – in other words, revenues from disasters flow over multiple periods.
Stocks Down Under Concierge gives you timely BUY and SELL alerts on ASX-listed stocks!
With price targets, buy ranges, stop loss levels and Sell alerts too.
GET A 3-MONTH FREE TRIAL TO CONCIERGE TODAY
No credit card needed and the trial expires automatically.
Blog Categories
Get Our Top 5 ASX Stocks for FY26
Recent Posts
Imricor Medical (ASX:IMR) FDA Approval Ignites Shares, but the Real Test Starts Now
FDA Approval Is a Big Win, Not the Finish Line Imricor Medical (ASX:IMR) received FDA clearance for its Vision-MR diagnostic…
How Nuclear Energy Became the World’s Most Feared Energy Source
Why Nuclear Energy Still Scares Us and What Really Went Wrong Many investors may remember periods when nuclear energy captured…
Dateline Resources (ASX:DTR) From 60c Highs to Hard Lessons
A Rare Earth Story the Market Loved Then Questioned For investors who have followed Dateline Resources (ASX:DTR), the past year…